Global Drug Eluting Stents Market Size Analysis, 2018-2028

REPORT ID: BKR650 Domain: Healthcare Published Date: April 2018

 

 

Global Drug Eluting Stents Market Size Analysis

The Global Drug Eluting Stents Market Size is estimated to be valued over USD 6.4 billion in 2018 with CAGR of 5.9% during the forecast period, 2018 – 2028. Cardiovascular diseases are the most common cause of death worldwide, coronary disease (CD) the most prevalent in Europe and North America. Various technological advancement in medical devices took place to subdue the increasing heart risk. Drug eluting stents has gained wide scale penetration in last one decade.

The industry is highly competitive with top five players accounting for over 85% of the market share. Fierce competition has led to a complete change in overall industry dynamics. While J&J used to dominate the share in 2010, it lost its market share to Medtronic – which is growing at a very impressive rate capturing most of the market share worldwide.

DES has significantly reduced the restenosis rate and has reduced mortality, morbidity, and healthcare costs associated with coronary artery disease treatment. According to World Health Organization (WHO), CVD is the leading cause of death worldwide, representing nearly 31% of global deaths. Furthermore, according to Centers for Disease Control and Prevention, nearly 610 thousand people die of heart disease each year in U.S., with over half of the deaths occurring due to Coronary heart disease. Increasing prevalence rate of such chronic disease will create significant demand drug eluting stents market.

Leading companies are investing heavily on R&D and product development to enhance their business reach globally. Recently, in 2017, Medtronic plc launched Resolute Onyx DES in United States post approval from FDA. These stents are available in 4.5 mm and 5.0 mm size.  Another major company – Elixir Medical – launched new drug eluting stents with trade name “Dynamxin 2017.  

Global Drug Eluting Stents Market Analysis, By Type

By Type, microporous surface stent is estimated to account for over 48% of global drug eluting market share in 2018. Government subsidies along with technological adoption will led to higher demand for such stent globally.

Global Drug Eluting Stents Market Analysis, By Therapeutic Application

Coronary artery disease will account for over 57% of global share in 2018. These stents are highly standardized with safety features and as such, its prominence has increased over other conventional approach.

Global Drug Eluting Stents Market Analysis, By End-use

Hospitals to account for over 79% of global sales in 2018. This is followed by specialty clinics and heart care centers.

North America to dominate global drug eluting stents market sales

Well reached distribution channel, presence of good medical coverage and high number of specialized healthcare personnel has led North America to dominate the global sales and is estimated to account for over 43% of sales in 2018. Though the region certainly dominates the global picture, it has lost over 700 basis points in last five years to Asia Pacific. This is primarily attributed to improving medical facilities in India and China and rise in per-capita disposable income. Moreover, cost of treatment is cheaper than North America by over 30 to 50%. Price capping by Government of India and China has further boosted sales.

Europe drug eluting stents market is next to North America in terms of overall sales, however, is expected to lose its position to Asia Pacific by 2020. Germany, UK, and France collectively accounted for 67% of regional sales in 2017.

Global Drug Eluting Stents Market Size and Forecast: Competition Landscape

Product launch and extensive distribution channels are key trends in the industry

Some key global drug eluting stents market players are Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Medtronic, Inc., Abbott Laboratories, HangZhou HuaAn Biotechnology Co.,Ltd, XTENT, Inc., Biosensors International Group, CARDIONOVUM GmbH, KYOTO MEDICAL PLANNING Co., Ltd., Boston Scientific Corporation, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, Biotronik, Lepu Medical Technology, Amaranth Medical, Inc.,

Drug Eluting Stents Market Industry Segmentation

By Type:

  • Polymer Free Coatings
    • Microporous Surface
    • Microstructured Surface
    • Slotted Tubular Surface
    • Nanoporous Surface
  • Polymer Based Coatings
    • Biodegradable
    • Non-biodegradable

By Therapeutic Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

By End-use:

  • Hospitals
    • Multi-Chain Hospitals
    • Independent Hospitals
  • Specialty Clinics
  • Cardiology Centers
  • Ambulatory Surgical Units

What Will You Discover in the Report?

  • An in-depth analysis of the Drug Eluting Stents market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
  • How the Drug Eluting Stents market sales is expected to grow throughout the forecast period.
  • How geopolitical policies and technological changes will affect the Drug Eluting Stents market in near future
  • Where the stakeholders should invest to generate higher profit margins
  • How consumers (end-users) will reflect to the Drug Eluting Stents industry during the forecast period
  • Who are the Drug Eluting Stents industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Drug Eluting Stents market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Drug Eluting Stents Market Size TOC

  1. Report Structure
  2. Research Methodology
    • Market Engineering Factors Weightage
    • Market Share Methodology
  3. Executive Summary
    • Key Findings
    • Market Engineering Factors
    • Industry Expert Perspectives
  4. Market Definitions
  5. The Global Drug Eluting Stents Market Value
    • Overall Market Forecast
    • Drug Eluting Stents Growth Outlook, By Segments
    • Drug Eluting Stents Growth Scenario, by Region
  6. The Drug Eluting Stents Industry Ecosystem
    • Parent Market Overview
    • Industry Value Chain and Distribution Analysis
    • Growth Factor Analysis
    • Key Industry Players By Region
    • Macro Factor Relational Value Analysis
  7. The Drug Eluting Stents Industry Dynamics
    • Drivers
      • Supply Side Drivers
      • Demand Side Drivers
      • Macroeconomic Factors
    • Challenges
    • Opportunities
    • Mega Trends
    • Geographical Trends
    • Industry Experts Views
    • Merger Acquisition
    • Regulatory Compliances, By Selected Countries
    • Key Industry Developments
  8. The Drug Eluting Stents Market Pricing Analysis
    • Drug Eluting Stents Pricing Forecast
    • Pricing Analysis By Region
    • Pricing Trends
  9. Global Drug Eluting Stents Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Industry Predictive Analysis
    • Drug Eluting Stents Industry Segment Comparative Ranking Analysis
    • Key Companies Involved and Initiatives
    • Global Industry Opportunity Proposition Analysis
    • Market Share Analysis, (%)
    • Global Drug Eluting Stents Market Size and Forecast, (2017-2028)
      • Market Value Forecast (US$ Million)
      • Growth Analysis (Y-o-Y) and Forecast
  1. Global Drug Eluting Stents Industry Size and Forecast, By Segments
  2. By Product Type:
    • By Type:
      • Polymer Free Coatings
        • Microporous Surface
        • Microstructured Surface
        • Slotted Tubular Surface
        • Nanoporous Surface
      • Polymer Based Coatings
        • Biodegradable
        • Non-biodegradable
      • By Therapeutic Application:
        • Coronary Artery Disease
        • Peripheral Artery Disease
      • By End-use:
        • Hospitals
          • Multi-Chain Hospitals
          • Independent Hospitals
        • Specialty Clinics
        • Cardiology Centers
        • Ambulatory Surgical Units
  1. By End-use:
    • Hospitals
      • Multi-Chain Hospitals
      • Independent Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Units
    • Diagnostic Centers
    • Academic and Research Centers
    • Others
  2. North America Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis
    • North America Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
      • North America Drug Eluting Stents Market, By Segments (As mentioned in section 10 of TOC)
    • S. Drug Eluting Stents Market Size and Forecast, By Segments
    • Canada Drug Eluting Stents Market Size and Forecast, By Segments
  3. Latin America Drug Eluting Stents Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Regional Countries
    • Latin America (South America) Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
      • Latin America Drug Eluting Stents Market, By Segments (As mentioned in section 10 of TOC)
    • Brazil Drug Eluting Stents Market Size and Forecast, By Segments
    • Argentina
    • Mexico
    • Rest of Latin America

(Drug Eluting Stents industry analysis covered across Latin America countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Western Europe Drug Eluting Stents Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Regional Countries
    • Western Europe Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
    • Western Europe Drug Eluting Stents Market, By Segments (As mentioned in section 10 of TOC)
    • Germany Drug Eluting Stents Market Size and Forecast, By Segments
    • UK
    • France
    • Spain
    • Italy
    • NORDIC
    • Switzerland
    • Rest of Western Europe

(Drug Eluting Stents industry analysis covered across Western Europe countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Central and Eastern Europe (CEE) Drug Eluting Stents Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Regional Countries
    • Central and Eastern Europe Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
    • Central and Eastern Europe Drug Eluting Stents Market, By Segments (As mentioned in section 10 of Drug Eluting Stents Market TOC)
    • Russia Drug Eluting Stents Market Size and Forecast, By Segments
    • Poland
    • Ukraine
    • Rest of CEE

(Drug Eluting Stents industry analysis is covered across Central and Eastern Europe countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Asia Pacific Drug Eluting Stents Industry Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Asia Pacific Countries
    • Asia Pacific Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
    • Asia Pacific Drug Eluting Stents Market, By Segments (As mentioned in section 10 of TOC)
    • Japan Drug Eluting Stents Market Size and Forecast, By Segments
    • China
    • India
    • South Korea
    • Australia
    • ASEAN
    • Rest of Asia Pacific

(Drug Eluting Stents industry analysis is covered across Asia Pacific countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Middle East Drug Eluting Stents Market Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Middle East Countries
    • Middle East Drug Eluting Stents Market Analysis
      • Industry Size and Forecast, (2017-2028)
      • Industry Share (%)
      • Industry Growth Forecast (%)
    • Middle East Drug Eluting Stents Market, By Segments (As mentioned in section 10 of TOC)
    • GCC Drug Eluting Stents Market Size and Forecast, By Segments
    • Israel
    • Rest of Middle East

(Drug Eluting Stents industry analysis is covered across Middle East countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Africa Drug Eluting Stents Market Value and Forecast
    • Introduction
    • Industry Initiatives
    • Bekryl Predictive Analysis
    • Comparative Ranking Analysis, By Segments (As mentioned in section 10)
    • Key Companies Involved and Initiatives, By Region
    • Industry Value Proposition Analysis, By Africa Countries
    • Market Share Analysis, (%)
    • Africa Drug Eluting Stents Industry Size and Forecast, (2017-2028)
    • Africa Drug Eluting Stents Industry Share (%)
    • Africa Drug Eluting Stents Industry Growth Forecast (%)
    • South Africa Drug Eluting Stents Market Size and Forecast, By Segments
    • Algeria
    • Nigeria

(Drug Eluting Stents industry analysis is covered across Africa countries by segments mentioned in section 10. Request Sample to access detailed TOC and Research Framework)

  1. Drug Eluting Stents Market Competitive Landscape
    • Competition Dashboard
    • Funding and Investment
    • Company Market Positioning
    • Marketing Mix Strategies
    • Product Level Strategies
    • Go-to-Market Strategies
    • SWOT Analysis
    • Key Developments, By Companies
    • Company Profiles*
      • Abbott Vascular Inc.,
      • AlviMedica Medical Technologies Inc.,
      • Medtronic, Inc.,
      • Abbott Laboratories,
      • HangZhou HuaAn Biotechnology Co.,Ltd,
      • XTENT, Inc.,
      • Biosensors International Group,
      • CARDIONOVUM GmbH,
      • KYOTO MEDICAL PLANNING Co., Ltd.,
      • Boston Scientific Corporation,
      • Terumo Medical Corporation,
      • Cook Medical,
      • Shandong JW Medical Systems,
      • Stentys,
      • Biotronik,
      • Lepu Medical Technology
      • Amaranth Medical, Inc.,
  1. Analyst Opinion
  2. Summary and Conclusion
  3. For more Information, Bekryl can help

*(SWOT, Key Developments, and Strategies are based on individual companies)

To access the detailed Drug Eluting Stents industry TOC and sample research pages, download sample.

  Get Sample Report

Drug Eluting Stents Market Report Structure

Drug Eluting Stents Industry Dynamics

This section enables Drug Eluting Stents industry stakeholders to understand the prevalent market conditions and help them prioritize their investment strategy. Factors that are favorable to Drug Eluting Stents market growth is equated with challenges – resulting in proper growth strategy module. Drivers and challenges provide early assessment of current Drug Eluting Stents industry trends and keep industry leaders abreast of latest happenings.

This section includes:

  • Market Drivers
  • Market Challenges
  • Drug Eluting Stents Industry Trends
  • Drug Eluting Stents Value Chain Analysis
  • Marketing Opportunities
  • Regulatory Aspects
  • Drug Eluting Stents Industry Experts Market Opinion

Industry Analysis, By Segments

Industry stakeholders receive detailed analysis of the Drug Eluting Stents industry trends. Anticipate key market trends across market analysis segments with Bekryl Market Analysts model.

Each segment has research framework, essential to understand the market scenario in near future.

Each segment includes:

  • Market Size and Forecast
  • Annual Growth Rate Analysis (AGR)
  • Key Trends, By segments
  • Key Industry Developments
  • Investment Proposition Analysis
  • Potential Addressable Market Analysis
  • Growth Factor, By Segment Analysis

This section helps in understanding the overall demand across end-users. As such, the industry stakeholders are able to minimize the operational cost and take better strategic decisions.

Competition Landscape

Keep abreast of key strategies of industry leaders and regional Drug Eluting Stents industry players. Company profiles allow industry stakeholders to competitor’s strategic decision and understand how these affect their own business.

This section include:

  • Competition dashboard
  • SWOT Analysis by Companies
  • Go-to-market sales strategy
  • Financial performances subject to listed companies
  • Market Share Analysis
  • Analyst Recommendation

 

Regional Market Analysis

Regional analysis help industry leaders to better understand the dynamics of their current market and determine which regional market their company should target to strengthen their market presence globally. The Drug Eluting Stents market report offers industry scenario in 24+ countries. Regional section focus on economic context, regulatory framework, supply demand balance trends and key regional companies engaged in the market.

This section include:

  • Market Size by Country and Region
  • Market Opportunity, By Country and Region
  • Regional Trends
  • Growth Analysis and Forecast

Country Profiles

Country profiles help industry leaders to better analyze the market at root level – thereby framing strategies that could add value to the overall organization. This section contains information pertaining to key developments and research framework mapping the potential attractive end-users. Factors are equated with macroeconomic conditions to help leaders minimize operational risks if any

North America Drug Eluting Stents Market Size

  • S.
  • Canada

Latin America Drug Eluting Stents Market Size

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

(*Drug Eluting Stents Market value analyzed across each Latin America country)

Western Europe Drug Eluting Stents Market Size

  • Germany
  • UK
  • France
  • Switzerland
  • Spain
  • Italy
  • NORDIC
  • Rest of Western Europe

(*Drug Eluting Stents Market value analyzed across each Western Europe country)

Central and Eastern Europe Drug Eluting Stents Industry Analysis

  • Russia
  • Poland Meat
  • Ukraine Meat
  • Rest of Eastern Europe

(*Drug Eluting Stents Market value analyzed across each Central and Eastern Europe country)

Asia Pacific Drug Eluting Stents Industry Size

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN Meat
  • Rest of Asia Pacific

(*Drug Eluting Stents Market value analyzed across each Asia Pacific country)

Middle East Drug Eluting Stents Industry Size

  • GCC
  • Israel
  • Rest of Middle East

(*Drug Eluting Stents Market value analyzed across each Middle East country)

Africa Drug Eluting Stents Industry Size

  • South Africa
  • Algeria
  • Nigeria
  • Rest of Africa

Drug Eluting Stents Market Research Methodology

Bekryl Market Analysts has earned reputation within the market research and consulting industry for its ability to not only collect and reprint data but also its ability to build upon its extensive models and databases to provide meaningful forecasting and strategic planning services to clients.

Our research analyst and industry experts thoroughly investigates the industry by extensively interviewing the industry leaders and analyzing information from various secondary sources. The information collected is analyzed with the help of analytical tools to offer real time forecast solutions.

Drug Eluting Stents Market Growth Forecasting Methodology

In order to prepare historical data and analyze Drug Eluting Stents market forecast, Bekryl prepare data for product supply and actual demand from end-use consumers. Through this, we get to know actual demand for Drug Eluting Stents market globally. The data collection is done through secondary and primary market research and then a constructive model is developed.

  • Secondary market research involves data collection through various paid publications and government agencies. Various journals and pre-encrypt transcripts is decoded to get the real time data solutions
  • The data collected through secondary research is then validated with the industry experts to minimize the anomaly and reflect key stakeholders opinion in the report.

With the model constructed, the cluttered data collected through different sources is structured with the help of proprietary analytical tools – making us understand the variation happened in the current year compared to historical years. To forecast Drug Eluting Stents market revenue, Bekryl Market Analysts takes in consideration the demand growth of the segments. Demand for the product is dependent on end-user spending which is a function of many factors: amongst them macroeconomic strength, price variation and other base factors.

The forecast methodology requires extensive data analysis across countries. Among all the factors, patients turnaround, spending patterns, healthcare amenities, and GVA and GDP output is considered as the first set of approximation. Bekryl Market Analysts has developed a demand driven model based on these factors across targeted countries.  Under this, co-relation is analyzed between product and the said parameters– resulting in a constant Product coefficient. Higher the coefficient- greater will be the growth rate. For instance, GDP-Product segment coefficient matrix of 3 denotes Drug Eluting Stents industry growth is nearly 3.5X to 5.5X higher than the relative GDP.

Besides Market Coefficient, Bekryl establishes following relation variation for higher predictive analysis.

  • Base Factors Growth Analysis
  • Price Variation Analysis
  • Potential Consumer Mapping

 

Drug Eluting Stents Industry Players: Competition Landscape Methodology

Bekryl maps key market players across regions. Financial ratios is taken in consideration along with regional presence and their value chain to understand the company market strength. Thereafter, investment proposition for each company is proposed which gives coefficient matrix value for the company. Industry experts is also reflected in company landscape.

 

Purchase
   

HOW WE ARE DIFFERENT

Bekryl widget

 

Growth Partnership

We work together with our clients to present strategic market research solutions that not only helps in understanding the net opportunity but also industry macroeconomic trends shaping the market. We extend our services to all types of industries ranging from inspiring startups to industry giants.

Tailored Solutions

We provide strategic solutions that help client meet their business needs. Our market research and consulting services includes wide range of organizations ranging from industries to educational and research institutes. Our well-equipped analytical team help client to explore digital platform for maximizing profits.

Industry Partnership

Bekryl Analysts track over 800 media channels and over 9000 market players to get the most blistering information on latest happening. It helps Bekryl to contribute consulting solutions that is proven and effective for clients.

CONNECT WITH US

Purchase